J&J invests heavily in Alzheimer's field

  • Follow Business

TRENTON, N.J. — Johnson & Johnson, making a big jump into the risky but potentially lucrative field of Alzheimer's disease, is taking a major stake in Irish biopharmaceutical company Elan Corp., investing up to $1.5 billion initially.

The two will cooperate to complete research on two injected drugs to stop progression of the mind-robbing disease and on a vaccine to prevent the buildup of plaque in the brain that causes increasing memory loss, confusion, wandering and aggression.

The deal, announced Thursday, sent Elan's U.S. shares up 60 cents, or 8.6 percent, to close at $7.60. J&J shares fell $1.09, or 1.9 percent, to $55.98.

The agreement would make J&J a major player in one of the biggest areas of unmet medical need and bring any successful treatments to market faster.

"It's good news for Alzheimer's patients and their families," said Erik Gordon, an analyst and professor at the University of Michigan's Ross School of Business.

New Brunswick, N.J.-based J&J, the world's biggest health care company with nearly $64 billion in 2008 sales, can pour far more money than Dublin-based Elan into the research, he said. J&J sells one Alzheimer's drug, Razadyne, with sales of just $541 million last year, but company executives last month said Alzheimer's disease is now a priority.

Several drugs help limit memory loss and other symptoms, but there are no treatments to stop or reverse brain damage caused by the disease. The market is huge: roughly 5.3 million current U.S. Alzheimer's patients, and more than 100 million worldwide expected eventually as the population ages.

J&J plans to commit up to $500 million initially for development of bapineuzumab, the compound furthest along in testing .

J&J will get Elan's 50 percent stake in its Alzheimer's immunotherapy research partnership with Madison, N.J.-based Wyeth, and set up a new joint company that will be 49.9 percent owned by Elan. J&J will gain all rights to any drugs approved; Elan will get 49.9 percent of the profits, plus royalties on sales.

Comments (1) Add comment
ADVISORY: Users are solely responsible for opinions they post here and for following agreed-upon rules of civility. Posts and comments do not reflect the views of this site. Posts and comments are automatically checked for inappropriate language, but readers might find some comments offensive or inaccurate. If you believe a comment violates our rules, click the "Flag as offensive" link below the comment.
soldout
1287
Points
soldout 07/03/09 - 11:10 am
0
0
Little reporting error here.

Little reporting error here. Alpha lipoic acid stops all progression and can be purchased at Wal-mart. Dr. David Williams has the details. Better yet; Nicotinamide, a form of B3 has cured it in mice and human studies are being done now. This info also available at Dr. David Williams site. It is amazing that alternative care continues to lap the field of the drug companies and regular doctor care. Whether it is NAET , EFT or other approaches alternative care is the clear winner and solves any medical crisis this country thinks it has. There is a whole world of exciting info out there in alternative care and it is 50 years ahead of everything else. The Word say; "we perish for the lack of knowledge". We also perish because no one reporrts on the cheap or free cures. Greed kills and it is doing it everyday in medical field.

Back to Top
loading...
Search Augusta jobs